SCHEMBL23070974

SCHEMBL23070974

COc1ccc(C(=O)N2CC3(CN(C(=O)OC(C)(C)C)C3)C2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.53
HPGD P15428 1/20 0.52
CYP3A4 P08684 4/20 0.51
CYP2C19 P33261 1/20 0.51
USP2 O75604 4/20 0.50
GPR119 Q8TDV5 1/20 0.49
ALDH1A1 P00352 3/20 0.49
KMT2A Q03164 2/20 0.49
MEN1 O00255 1/20 0.49
CYP2C9 P11712 3/20 0.48
HIF1A Q16665 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
MAPK1 P28482 1/20 0.48
CYP1A2 P05177 3/20 0.47
KDM4E B2RXH2 2/20 0.47
HTT P42858 1/20 0.47
POLB P06746 1/20 0.47
MAPT P10636 2/20 0.47
LMNA P02545 1/20 0.47
GPR183 P32249 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28494646 0.85 MEN1 (0.67) TSHRHPGDGPR119ALDH1A1KMT2A
SCHEMBL23071049 0.81 CHRNB2 (0.63) HPGDGPR119ALDH1A1KMT2AMEN1
SCHEMBL16874872 0.78 ALDH1A1 (0.51) GPR119ALDH1A1SMN1; SMN2KDM4EHTT
SCHEMBL23071019 0.77 TSHR (0.58) TSHRHPGDCYP3A4CYP2C19USP2
SCHEMBL1394450 0.77 USP2 (0.52) HPGDUSP2GPR119SMN1; SMN2GPR183
SCHEMBL31464333 0.77 GPR183 (0.47) GPR119KMT2AMEN1POLBGPR183
SCHEMBL23381770 0.77 BACE1 (0.52) GPR119ALDH1A1SMN1; SMN2KDM4EHTT
SCHEMBL25284527 0.76 MEN1 (0.40) KMT2AMEN1GPR183
SCHEMBL31004992 0.75 ALDH1A1 (0.48) GPR119ALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL22127635 0.74 MAPT (0.55) HPGDCYP2C19GPR119ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112442050-B RET inhibitor, pharmaceutical composition and application thereof 广东东阳光药业股份有限公司 2024-08-09 CN disclosed
CN-112574235-B RET inhibitor, pharmaceutical composition and application thereof 广东东阳光药业股份有限公司 2024-01-16 CN disclosed
WO-2021057963-A1 RET INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME AND USE THEREOF 广东东阳光药业有限公司 2021-04-01 WO disclosed
WO-2021043209-A1 RET INHIBITOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF 广东东阳光药业有限公司 2021-03-11 WO disclosed